Day 4 Recap: Elevate-Derm West 2024 Dermatology Times Source link
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis Dermatology Times Source link
The Weekly Roundup: October 7-11 Dermatology Times Source link